Published in Transplant Proc on February 01, 1993
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys (1979) 2.49
The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch Biochem Biophys (1979) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem (1976) 2.15
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Control of the general amino acid permease of Penicillium chrysogenum by transinhibition and turnover. Arch Biochem Biophys (1973) 1.85
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch Biochem Biophys (1979) 1.73
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
Effect of weak acids on amino acid transport by Penicillium chrysogenum: evidence for a proton or charge gradient as the driving force. J Bacteriol (1973) 1.58
Acidic and basic amino acid transport systems of Penicillium chrysogenum. Arch Biochem Biophys (1971) 1.54
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Transplantation of pediatric donor kidneys to adult recipients. Is there a critical donor age? Ann Surg (1986) 1.26
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant (2002) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Pediatric renal transplants--results with sequential immunosuppression. Transplantation (1992) 1.16
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin, and fibroblast surface antigens in normal, diseased, and transplanted human kidneys. Am J Pathol (1978) 1.14
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 1.13
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg (1993) 1.12
Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation (1999) 1.11
Contracture in isolated adult rat heart cells. Role of Ca2+, ATP, and compartmentation. Circ Res (1981) 1.10
Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet (1975) 1.09
Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis. Am J Med (1976) 1.08
Na+ releases Ca2+ from liver, kidney and lung mitochondria. FEBS Lett (1980) 1.07
Allosteric inhibition of the Ca2+-activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. J Membr Biol (1980) 1.07
Short-term culture of adult pancreatic fragments for purification and transplantation of islets of Langerhans. Surgery (1976) 1.07
Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel. J Mol Cell Cardiol (1981) 1.05
Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation (1992) 1.05
Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc (1979) 1.04
Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation (1994) 1.04
Modulation of cellular calcium stores in the perfused rat heart by isoproterenol and ryanodine. Circ Res (1983) 1.04
Renal transplantation in infants. Ann Surg (1990) 1.04
Respiratory control in cytochrome oxidase. Biochem Biophys Res Commun (1974) 1.03
Use of cardioprotective medications in kidney transplant recipients. Am J Transplant (2009) 1.03
Economic impact of delayed graft function. Transplant Proc (1991) 1.02
The dispersed pancreas: transplantation without islet purification in totally pancreatectomized dogs. Diabetologia (1977) 1.01
Gas-generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation (1996) 1.01
Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation (1993) 1.01
The isolation of Ca2+-resistant myocytes from the adult rat. J Mol Cell Cardiol (1980) 1.01
Cellular calcium turnover in the perfused rat heart: modulation by caffeine and procaine. Circ Res (1982) 1.01
Inhibition of calcium influx in isolated adult rat heart cells by ATP depletion. Circ Res (1987) 1.00
Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. Transplant Proc (1990) 1.00
Letter: Increased serum creatinine resulting from hyperglycemia, mimicking transplant rejection. Ann Intern Med (1975) 1.00
Laparoscopic drainage of lymphoceles after kidney transplantation: indications and limitations. Surgery (1995) 1.00
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.00
Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes (1980) 0.99
Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation (1993) 0.98
Autotransplantation of pancreatic fragments to the portal vein and spleen of totally pancreatectomized dogs: a comparative evaluation. Ann Surg (1978) 0.98
Predicting clinical outcome in the elderly renal transplant recipient. Kidney Int (2000) 0.98
Pregnancy after donor nephrectomy. Transplantation (1996) 0.97
Donor scoring system for cadaveric renal transplantation. Am J Transplant (2001) 0.96
Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplant (1999) 0.96
Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am (2009) 0.96
Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg (1991) 0.96
Assessing elements of informed consent among living donors. Clin Transplant (2010) 0.96
Glomerular basement membrane thickness following islet transplantation in the diabetic rat. Lab Invest (1979) 0.96
The fate of intraportally transplanted islets in diabetic rats. A morphologic and immunohistochemical study. Am J Pathol (1978) 0.95
Kidney transplant recipients who die with functioning grafts: serum creatinine level and cause of death. Transplantation (1996) 0.95
A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation (1994) 0.95
Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidney Dis (1999) 0.94
Kidney retransplants after initial graft loss to vascular thrombosis. Clin Transplant (2001) 0.94
Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. Am J Transplant (2012) 0.93
Transplant center regulations--a mixed blessing? An ASTS Council viewpoint. Am J Transplant (2008) 0.93
Effect of cycloheximide on L-leucine transport by Penicillium chrysogenum: involvement of calcium. J Bacteriol (1973) 0.93
Living donors >55 years: to use or not to use? Transplantation (1999) 0.93
Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int (1994) 0.92
Earlier is not necessarily better in preemptive kidney transplantation. Am J Transplant (2008) 0.92
Control of the mitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. J Bioenerg Biomembr (2000) 0.92
Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation (1995) 0.92